We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Humana (HUM) Reports Q2 Earnings: What Key Metrics Have to Say
Read MoreHide Full Article
Humana (HUM - Free Report) reported $25.73 billion in revenue for the quarter ended June 2023, representing a year-over-year increase of 8.8%. EPS of $8.94 for the same period compares to $8.67 a year ago.
The reported revenue represents a surprise of -0.34% over the Zacks Consensus Estimate of $25.82 billion. With the consensus EPS estimate being $8.88, the EPS surprise was +0.68%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Humana performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Medical Membership - Group Medicare Advantage: 509.5 thousand versus the five-analyst average estimate of 505.78 thousand.
Medical Membership - Medicare Supplement: 294.3 thousand compared to the 300.14 thousand average estimate based on five analysts.
Medical Membership - State-based contracts and other: 1330.2 thousand versus 1297.43 thousand estimated by five analysts on average.
Medical Membership - Medicare stand-alone PDP: 2915.3 thousand compared to the 2857.07 thousand average estimate based on five analysts.
Revenues- Premiums: $25.50 billion versus the seven-analyst average estimate of $24.73 billion. The reported number represents a year-over-year change of +14.5%.
Revenues- Services: $978 million versus $986.78 million estimated by six analysts on average.
Revenues- Investment income (loss): $274 million versus $208.88 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +483% change.
Revenues- Consolidated- Premiums- Total Medicare: $22.05 billion versus $21.97 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +15.1% change.
Revenues- Consolidated- Premiums- Medicaid and other: $2.06 billion versus $1.95 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +32.5% change.
Revenues- Consolidated- Premiums- Medicare stand-alone PDP: $568 million compared to the $535.15 million average estimate based on five analysts. The reported number represents a change of -6.3% year over year.
Revenues- Consolidated- Premiums- Individual Medicare Advantage: $19.75 billion versus the five-analyst average estimate of $19.68 billion. The reported number represents a year-over-year change of +18.3%.
Revenues- Consolidated- Services revenue- Provider Services: $190 million versus the five-analyst average estimate of $186.95 million. The reported number represents a year-over-year change of +38.7%.
Shares of Humana have returned +2.7% over the past month versus the Zacks S&P 500 composite's +3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Humana (HUM) Reports Q2 Earnings: What Key Metrics Have to Say
Humana (HUM - Free Report) reported $25.73 billion in revenue for the quarter ended June 2023, representing a year-over-year increase of 8.8%. EPS of $8.94 for the same period compares to $8.67 a year ago.
The reported revenue represents a surprise of -0.34% over the Zacks Consensus Estimate of $25.82 billion. With the consensus EPS estimate being $8.88, the EPS surprise was +0.68%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Humana performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Medical Membership - Group Medicare Advantage: 509.5 thousand versus the five-analyst average estimate of 505.78 thousand.
- Medical Membership - Medicare Supplement: 294.3 thousand compared to the 300.14 thousand average estimate based on five analysts.
- Medical Membership - State-based contracts and other: 1330.2 thousand versus 1297.43 thousand estimated by five analysts on average.
- Medical Membership - Medicare stand-alone PDP: 2915.3 thousand compared to the 2857.07 thousand average estimate based on five analysts.
- Revenues- Premiums: $25.50 billion versus the seven-analyst average estimate of $24.73 billion. The reported number represents a year-over-year change of +14.5%.
- Revenues- Services: $978 million versus $986.78 million estimated by six analysts on average.
- Revenues- Investment income (loss): $274 million versus $208.88 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +483% change.
- Revenues- Consolidated- Premiums- Total Medicare: $22.05 billion versus $21.97 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +15.1% change.
- Revenues- Consolidated- Premiums- Medicaid and other: $2.06 billion versus $1.95 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +32.5% change.
- Revenues- Consolidated- Premiums- Medicare stand-alone PDP: $568 million compared to the $535.15 million average estimate based on five analysts. The reported number represents a change of -6.3% year over year.
- Revenues- Consolidated- Premiums- Individual Medicare Advantage: $19.75 billion versus the five-analyst average estimate of $19.68 billion. The reported number represents a year-over-year change of +18.3%.
- Revenues- Consolidated- Services revenue- Provider Services: $190 million versus the five-analyst average estimate of $186.95 million. The reported number represents a year-over-year change of +38.7%.
View all Key Company Metrics for Humana here>>>Shares of Humana have returned +2.7% over the past month versus the Zacks S&P 500 composite's +3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.